Pasireotide is a second-generation somatostatin receptor ligand (SRL) with the highest affinity for somatostatin receptor subtype 5 (SSTR5), the most abundantly expressed SSTR in corticotropinomas [7,8,9]. The gene discussed is SSTR5; the disease is ACTH-producing pituitary gland adenoma.